What is myelogenic leukemia?
myelogenic leukemia is bone marrow cancer and blood. It can develop and proceed very quickly and usually affects immature blood cells in the bone marrow. In addition, it affects white blood cells, also known as myeloid cells. Myeloid cells usually develop on several types of ripe blood cells, including red blood cells, plates and white blood cells. Myelogenic leukemia passes through several other names: acute myelogenic leukemia, acute myeloid leukemia, acute granulocytic leukemia, acute myeloblastic leukemia and acute non -elypocytic leukemia.
Symptoms associated with myelogenic leukemia are important for early detection. Unfortunately, many symptoms of the disease during its initial phases may seem like a common disease like the flu. In addition, symptoms may vary depending on the type of blood cells affected. General symptoms include fever, weight loss, pain and pain that seem to come to come, fatigue, lethargy, skin paleness, frequent illnesses, bruisesWell, frequent noseblees and bleeding rubber.
Although it is not clear why most people have leukemia in any forms, scientists have general information about the causes of myelogenic leukemia. In most cases, the DNA cells that develop in the bone marrow are damaged - often due to exposure to radiation, chemicals and even drug chemotherapy. Damaged cells cause the entire blood cell production to light. As a result, bone marrow grows immature blood cells that turn into leukemic white blood cells or myeloblasts. Abnormal cells have overcome and prevent healthy cell growth.
To determine whether a person has acute myelogenic leukemia, tests are likely to be performed. Blood tests will indicate whether a person has an excess of white loop cells and insufficient amounts of red blood cells and plates. In addition, the blood test can determine whether there are immature cells that are usually in the blood only inbone marrow. In addition, bone marrow biopsy usually occurs to take a bone marrow sample for testing. Finally, leukemic cells of spinal copying or lumbar puncture may be tested.
As soon as the doctor confirms that the person has myelogenic leukemia, oncologist or hematologist will work to determine how far it is along cancer and subtype of cancer. The subtypes are divided according to the maturity of cancer cells, the degree of mutation and the location and the number of cancer cells. Based on the subtype and the scope of cancer, various treatments are recommended, from remission therapy to chemotherapy or medicinal therapy. There is also an abundance of alternative techniques that may try to reduce or alleviate symptoms such as acupuncture and meditation.